ARCHIVES

Health Reform Bill Contains Unpleasant Surprises For Drug Manufacturers

This article is from The Cancer Letter archive.

Vol. 19 No. 43 | November 5, 1993

Download PDF Visit The Full Archive

Related Articles

Ceritinib Demonstrates 58% ORR, 7-month PFS in ALK+ NSCLC

March 28, 2014

UT-Houston Wins NIH Center Grant For Alternative Cancer Medicine Studies

November 3, 1995

Breast Cancer Risk Rises To 1 Woman In 9

February 1, 1991

In Brief: Baltimore Resigns as Rockefeller President; Perry Named Medical Director At Ellis Fischel

December 13, 1991

NCAB Subcommittee Suggests Comp Centers Must Have Core Grants

September 22, 1978

Ruffin Sworn In As Director, NIH Minority Health Center.

January 12, 2001